Home Stocks Crescent Biopharma, Inc. Insider trades Crescent Biopharma, Inc. · LS:A41BDZ
Crescent Biopharma, Inc. insider trades Crescent Biopharma, Inc.'s insiders made 1 buy and 16 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.
Insider trades Trade Trade Shares Price Value Date McNeill Jonathan Officer: President and COO
Sale 3,839 USD 16.71 US$64,150 Sep 18, 2026 Brumm Joshua T Director, Officer: Chief Executive Officer
Sale 7,837 USD 16.71 US$131K Sep 18, 2026 McNeill Jonathan Officer: President and COO
Sale 731 USD 17.90 US$13,085 Sep 16, 2026 Brumm Joshua T Director, Officer: Chief Executive Officer
Sale 1,610 USD 17.90 US$28,819 Sep 16, 2026 Bispham Barbara Harlin Officer: See Remarks
Sale 620 USD 17.90 US$11,098 Sep 16, 2026 Scalzo Richard William Officer: Chief Financial Officer
Sale 568 USD 17.90 US$10,167 Sep 16, 2026 Im Ellie Eunkyung Officer: Chief Medical Officer
Sale 623 USD 17.90 US$11,152 Sep 16, 2026 Pinkas Jan Officer: Chief Scientific Officer
Sale 658 USD 17.90 US$11,778 Sep 16, 2026 Lynch Ryan Officer: See Remarks
Sale 240 USD 17.90 US$4,296 Sep 16, 2026 Fairmount Healthcare Fund II L.P. Director, 10% owner
Buy 853,450 USD 14.50 US$12.4M Jul 16, 2026 Brumm Joshua T Director, Officer: Chief Executive Officer
Sale 42,305 USD 17.99 US$761K Jun 22, 2026 McNeill Jonathan Officer: President and COO
Sale 20,549 USD 17.99 US$370K Jun 22, 2026 Im Ellie Eunkyung Officer: Chief Medical Officer
Sale 1,219 USD 17.99 US$21,930 Jun 22, 2026 Bispham Barbara Harlin Officer: See Remarks
Sale 1,218 USD 17.99 US$21,912 Jun 22, 2026 Scalzo Richard William Officer: Chief Financial Officer
Sale 1,112 USD 17.99 US$20,005 Jun 22, 2026 Pinkas Jan Officer: Chief Scientific Officer
Sale 1,288 USD 17.99 US$23,171 Jun 22, 2026 Lynch Ryan Officer: See Remarks
Sale 465 USD 17.99 US$8,365 Jun 22, 2026